Loading…
← CockpitCompetitor Analysis › 300848.SZ Miracll Chemicals Co. Ltd. Class AOpen in the cockpit ↗

Miracll Chemicals Co. Ltd. Class A300848.SZCompetitor analysis, valuation and peers

China · CNY·Materials›Chemicals: Specialty
Momentum laggard 15
Mkt cap
$578M
US dollars, full cap
Free float
42%
of shares outstanding
$/day
$4.54M
20-day average traded
Fwd P/E
11.1×
forward earnings
ROIC−WACC
-4.3 pp
WACC 6.8%
Hurdle
n/a
no reverse DCF
Next earnings
160 days
27 Apr 2027
Close · CNYCN¥9.10
1D-1.3%
1W-9.9%
1M-10.7%
3M-28.5%
6M-46.1%
YTD-42.5%
1Y-52.7%
ATR %3.9%
52w lowhigh53.6% off high

What Miracll Chemicals does

Employees: 649

Miracll Chemicals at a glance

Size Miracll Chemicals (300848.SZ) is a China Materials company (Chemicals: Specialty) with a market value of $578M, the 3342nd largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥9.10 on 18 Nov 2026.

Performance Over six months the shares fell 46.1%, against -26.4% for the median peer and -20.0% for the China market (cap-weighted) — 5th lowest of 21 in its peer set.

Growth Revenue grew 23.2% over the last twelve months (peer median +19.5%); the operating margin is 0.8% (peer median 8.4%).

Valuation It trades at 11.1× forward earnings against a peer median of 13.1× (7th cheapest of 15).

Capital Return on invested capital runs 4.3 points below its cost of capital (6.8% WACC).

Next results Next results expected around 27 Apr 2027 (exchange calendar; dates can move).

Relative performance

608010021 May 202621 Aug 202618 Nov 2026Peer median 72300848.SZ 55
Six months, rebased to 100: Miracll Chemicals against the median of its 20 peers (local-currency closes).

Miracll Chemicals financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥2.09BCN¥1.74BCN¥1.66BCN¥1.47BCN¥1.47B
Revenue growth—+5%+13%0%—
Gross profitCN¥302MCN¥215MCN¥202MCN¥192MCN¥193M
EBITDAn/aCN¥145MCN¥97.0MCN¥98.4MCN¥103M
Net incomeCN¥36.5MCN¥81.9MCN¥77.6MCN¥87.9MCN¥111M
Free cash flow-CN¥420M-CN¥66.6M-CN¥806M-CN¥554M-CN¥355M
Capital expenditureCN¥294MCN¥393MCN¥674MCN¥786MCN¥373M
Total debtCN¥2.18BCN¥2.06BCN¥1.80BCN¥1.40BCN¥564M

Quarterly statements and history in the cockpit →

Miracll Chemicals competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%0%+50%-20%0%30124649714461121600603790603822301395603212LCFS2465KOPIOLCP688386002637300478KRNT2851304116300848.SZ6-month return →1-month return →
Up and to the right = strong over both horizons. Miracll Chemicals is the large dot.

Fundamentals: revenue growth against valuation

0%+50%+100%0×50×100×150×49714461121600603822603212LCFS2465KOPIOLCP688386002637KRNT285130004000300848.SZRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Miracll Chemicals is the large dot.

Miracll Chemicals competitors and peer comparison

How Miracll Chemicals compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Miracll Chemicals against its 20 peers (data as of 18 Nov 2026)
Measure300848.SZPeer medianRank in peer set
1-month return-10.7%-12.9%9th highest of 21
6-month return-46.1%-26.4%5th lowest of 21
Distance from 52-week high-53.6%-49.9%9th lowest of 21
Revenue growth (TTM)+23.2%+19.5%9th highest of 21
Operating margin0.8%8.4%6th lowest of 21
Forward P/E11.1×13.1×7th cheapest of 15
ROIC minus cost of capital-4.3 pp-1.1 pp7th lowest of 21

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Miracll Chemicals 300848.SZChina$578M-46%+23%1%11.1×n/an/a
Hubei Hongyuan Pharmaceutical Technology 301246.SZChina$576M-57%+45%12%n/an/an/a
MEC 4971.TJapan$582M-52%+31%32%14.7×16.1%+11.9%
DKS 4461.TJapan$573M+3%+31%15%9.5×7.2%+7.0%
Advanced Nano Products 121600.KSSouth Korea$572M-11%+33%12%47.1×27.9%+18.2%
Argus (Shanghai) Textile Chemicals 603790.SSChina$572M-30%+21%14%n/a10.6%+0.7%
Zhejiang Jiaao Enprotech Stock 603822.SSChina$585M-27%+101%19%7.9×-9.8%+31.6%
Renxin New Material 301395.SZChina$587M+13%+1%-6%n/an/an/a
Cybrid Technologies 603212.SSChina$588M-40%-9%-7%162.9×n/an/a
Tidewater Renewables LCFS.TOCanada$567M+71%+103%25%11.6×-12.6%+126.4%
Jiangsu Lopal Tech 2465.HKHong Kong$590M-61%+107%7%4.8×n/an/a
Koppers KOPUnited States$563M-24%-1%9%8.0×-3.9%+2.4%
IOL Chemicals & Pharmaceuticals IOLCP.NSIndia$596M+72%+27%10%22.3×27.1%+3.5%
Pan Asian Microvent Tech (Jiangsu) 688386.SSChina$598M-50%+12%15%36.6×n/an/a
Zanyu Technology 002637.SZChina$558M-40%-3%3%8.6×-1.8%+11.0%
Hangzhou Gaoxin Materials Technology 300478.SZChina$600M-21%-21%-9%n/a29.9%-0.9%
Jiangsu Baichuan High-Tech New Materials 002455.SZChina$604M-43%+9%1%n/an/an/a
Kornit Digital KRNTUnited States$549M-11%+5%-16%59.3×n/an/a
Skchem 285130.KSSouth Korea$548M-26%+22%0%18.2×n/an/a
LOTTE Fine Chem 004000.KSSouth Korea$610M-45%+18%7%4.3×-20.1%+6.8%
Dainichiseika Color & Chemicals Mfg.Co 4116.TJapan$610M+23%+5%8%n/a1.8%-2.1%

Questions

Which companies are Miracll Chemicals's closest peers?
The cockpit's peer set: Hubei Hongyuan Pharmaceutical Technology (301246.SZ), MEC (4971.T), DKS (4461.T), Advanced Nano Products (121600.KS), Argus (Shanghai) Textile Chemicals (603790.SS), Zhejiang Jiaao Enprotech Stock (603822.SS), Renxin New Material (301395.SZ), Cybrid Technologies (603212.SS).
Is Miracll Chemicals expensive compared with its peers?
On forward p/e it trades at 11.1× against a peer median of 13.1×, 7th cheapest of 15 in its peer set.
How has Miracll Chemicals stock performed?
Over six months to 18 Nov 2026 the shares returned -46.1% against -26.4% for the median peer; over one year -52.7%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.